Publicacions (101) Publicacions en què ha participat algun/a investigador/a

2024

  1. A Dual-Armed Oncolytic Virus Shows Clinical Efficacy in Advanced Solid Cancers

    Clinical Cancer Research, Vol. 30, Núm. 17, pp. 3649-3651

  2. A Focus on the Pathophysiology of Adrenomedullin Expression: Endothelitis and Organ Damage in Severe Viral and Bacterial Infections

    Cells, Vol. 13, Núm. 11

  3. A Pilot Study on Proteomic Predictors of Mortality in Stable COPD

    Cells, Vol. 13, Núm. 16

  4. A plasma peptidomic signature reveals extracellular matrix remodeling and predicts prognosis in alcohol-associated hepatitis

    Hepatology Communications, Vol. 8, Núm. 8

  5. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  6. Adecuación de la PROfilaxis del TromboEmbolismo venoso en los Servicio de Urgencias españoles: estudio PROTESU II

    Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias, Vol. 36, Núm. 3, pp. 232-233

  7. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

    Archivos de Bronconeumologia, Vol. 60, Núm. 3, pp. 143-152

  8. Alcohol Drinking Impacts on Adiposity and Steatotic Liver Disease: Concurrent Effects on Metabolic Pathways and Cardiovascular Risks

    Current Obesity Reports, Vol. 13, Núm. 3, pp. 461-474

  9. Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1

    JHEP Reports, Vol. 6, Núm. 1

  10. Application of Graph Models to the Identification of Transcriptomic Oncometabolic Pathways in Human Hepatocellular Carcinoma

    Biomolecules, Vol. 14, Núm. 6

  11. Binge drinking at time of bariatric surgery is associated with liver disease, suicides, and increases long-term mortality

    Hepatology Communications, Vol. 8, Núm. 8

  12. Bridging Metabolic-Associated Steatotic Liver Disease and Cardiovascular Risk: A Potential Role for Ketogenesis

    Biomedicines, Vol. 12, Núm. 3

  13. COPD: systemic proteomic profiles in frequent and infrequent exacerbators

    ERJ Open Research, Vol. 10, Núm. 2

  14. Can anticoagulation be withdrawn in APS patients after aPL negativization?

    Autoimmunity Reviews, Vol. 23, Núm. 1

  15. Caspases compromise SLU7 and UPF1 stability and NMD activity during hepatocarcinogenesis

    JHEP Reports, Vol. 6, Núm. 8

  16. Characterization of a Trispecific PD-L1 Blocking Antibody That Exhibits EGFR-Conditional 4-1BB Agonist Activity

    ANTIBODIES, Vol. 13, Núm. 2

  17. Characterization of brain transduction capability of a BBB-penetrant AAV vector in mice, rats and macaques reveals differences in expression profiles

    Gene Therapy, Vol. 31, Núm. 9-10, pp. 455-466

  18. Circulating miR-122-5p, miR-151a-3p, miR-126-5p and miR-21-5p as potential predictive biomarkers for Metabolic Dysfunction-Associated Steatotic Liver Disease assessment

    Journal of Physiology and Biochemistry

  19. Clinical Perspectives, Eligibility, and Success Criteria for Bariatric/Metabolic Surgery

    Advances in experimental medicine and biology, Vol. 1460, pp. 677-695

  20. Clinical Presentation and Outcomes of Patients with Cancer-Associated Isolated Distal Deep Vein Thrombosis

    Journal of Clinical Oncology, Vol. 42, Núm. 5, pp. 529-537